ZFIN ID: ZDB-TALEN-170828-2
TALEN Name: TALEN1-prl
Target: prl (1)
Source:
Target Sequence 1:
5' - GTTCTAGTAATGGCTC - 3'
   
Select Sequence Analysis Tool

Target Sequence 2:
5' - AAGATACCTGCAAAGT - 3'
   
Select Sequence Analysis Tool

  (Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.)
TARGET LOCATION
No data available
CONSTRUCTS WITH SEQUENCES FROM TALEN1-prl No data available
GENOMIC FEATURES CREATED WITH TALEN1-prl
Genomic Feature Affected Genomic Regions    
ihb182 prl    
ihb183 prl    
GENE EXPRESSION
Gene expression in Wild Types + TALEN1-prl No data available
PHENOTYPE
Phenotype resulting from TALEN1-prl
No data available

Phenotype of all Fish created by or utilizing TALEN1-prl
Phenotype Fish Conditions Figures
head slc12a10.2 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 4 with image from Shu et al., 2016
whole organism edematous, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
corpuscles of Stannius stc1 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 6 with image from Shu et al., 2016
xanthophore decreased amount, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
pronephros slc9a3.2 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 5 with image from Shu et al., 2016
pronephric proximal straight tubule vH ionocyte ca2 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 3 with image from Shu et al., 2016
head ca2 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 3 with image from Shu et al., 2016
heart edematous, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
whole organism chloride amount, ameliorated prlihb182/ihb182 hypertonic Fig. 2 with image from Shu et al., 2016
swim bladder inflation decreased occurrence, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
whole organism decreased life span, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
head atp1a1a.5 expression increased amount, abnormal prlihb182/ihb182 control Fig. 4 with image from Shu et al., 2016
whole organism curved, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
NaK ionocyte atp1b1b expression increased amount, abnormal prlihb182/ihb182 control Fig. 3 with image from Shu et al., 2016
whole organism atp1a1a.5 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 5 with image from Shu et al., 2016
whole organism shortened, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
pronephric proximal convoluted tubule vH ionocyte ca2 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 3 with image from Shu et al., 2016
whole organism slc9a3.2 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 5 with image from Shu et al., 2016
head atp1b1b expression increased amount, abnormal prlihb182/ihb182 control Fig. 3 with image from Shu et al., 2016
gill NCC ionocyte slc12a10.2 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 4 with image from Shu et al., 2016
bone development delayed, abnormal prlihb182/ihb182 hypotonic, low calcium Fig. 6 with image from Shu et al., 2016
bone development occurrence, ameliorated prlihb182/ihb182 hypertonic, high calcium Fig. 6 with image from Shu et al., 2016
gill trpv6 expression increased amount, abnormal prlihb182/ihb182 control Fig. 6 with image from Shu et al., 2016
gill vH ionocyte atp1a1a.5 expression increased amount, abnormal prlihb182/ihb182 control Fig. 4 with image from Shu et al., 2016
whole organism sodium(1+) amount, ameliorated prlihb182/ihb182 hypertonic Fig. 2 with image from Shu et al., 2016
whole organism potassium(1+) decreased amount, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
whole organism slc12a3 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 5 with image from Shu et al., 2016
gill sodium(1+) decreased amount, abnormal prlihb182/ihb182 control Fig. 4 with image from Shu et al., 2016
head trpv6 expression increased amount, abnormal prlihb182/ihb182 control Fig. 6 with image from Shu et al., 2016
whole organism chloride decreased amount, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
pronephros slc12a3 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 5 with image from Shu et al., 2016
whole organism life span, ameliorated prlihb182/ihb182 hypertonic Fig. 2 with image from Shu et al., 2016
pronephric duct vH ionocyte ca2 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 3 with image from Shu et al., 2016
whole organism potassium(1+) amount, ameliorated prlihb182/ihb182 hypertonic Fig. 2 with image from Shu et al., 2016
whole organism sodium(1+) decreased amount, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
pronephros atp1a1a.5 expression decreased amount, abnormal prlihb182/ihb182 control Fig. 5 with image from Shu et al., 2016
whole organism swollen, abnormal prlihb182/ihb182 control Fig. 2 with image from Shu et al., 2016
head slc12a10.2 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 4 with image from Shu et al., 2016
whole organism decreased life span, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
whole organism edematous, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
pronephros slc9a3.2 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 5 with image from Shu et al., 2016
xanthophore decreased amount, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
pronephric proximal straight tubule vH ionocyte ca2 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 3 with image from Shu et al., 2016
corpuscles of Stannius stc1 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 6 with image from Shu et al., 2016
swim bladder inflation decreased occurrence, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
head ca2 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 3 with image from Shu et al., 2016
whole organism chloride amount, ameliorated prlihb183/ihb183 hypertonic Fig. 2 with image from Shu et al., 2016
heart edematous, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
head atp1a1a.5 expression increased amount, abnormal prlihb183/ihb183 control Fig. 4 with image from Shu et al., 2016
whole organism curved, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
NaK ionocyte atp1b1b expression increased amount, abnormal prlihb183/ihb183 control Fig. 3 with image from Shu et al., 2016
pronephric proximal convoluted tubule vH ionocyte ca2 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 3 with image from Shu et al., 2016
whole organism slc9a3.2 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 5 with image from Shu et al., 2016
whole organism atp1a1a.5 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 5 with image from Shu et al., 2016
gill vH ionocyte atp1a1a.5 expression increased amount, abnormal prlihb183/ihb183 control Fig. 4 with image from Shu et al., 2016
head atp1b1b expression increased amount, abnormal prlihb183/ihb183 control Fig. 3 with image from Shu et al., 2016
bone development occurrence, ameliorated prlihb183/ihb183 hypertonic, high calcium Fig. 6 with image from Shu et al., 2016
bone development delayed, abnormal prlihb183/ihb183 hypotonic, low calcium Fig. 6 with image from Shu et al., 2016
gill NCC ionocyte slc12a10.2 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 4 with image from Shu et al., 2016
gill trpv6 expression increased amount, abnormal prlihb183/ihb183 control Fig. 6 with image from Shu et al., 2016
whole organism sodium(1+) amount, ameliorated prlihb183/ihb183 hypertonic Fig. 2 with image from Shu et al., 2016
whole organism potassium(1+) decreased amount, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
whole organism shortened, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
gill sodium(1+) decreased amount, abnormal prlihb183/ihb183 control Fig. 4 with image from Shu et al., 2016
whole organism swollen, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
whole organism chloride decreased amount, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
whole organism slc12a3 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 5 with image from Shu et al., 2016
pronephros slc12a3 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 5 with image from Shu et al., 2016
head trpv6 expression increased amount, abnormal prlihb183/ihb183 control Fig. 6 with image from Shu et al., 2016
whole organism life span, ameliorated prlihb183/ihb183 hypertonic Fig. 2 with image from Shu et al., 2016
whole organism potassium(1+) amount, ameliorated prlihb183/ihb183 hypertonic Fig. 2 with image from Shu et al., 2016
whole organism sodium(1+) decreased amount, abnormal prlihb183/ihb183 control Fig. 2 with image from Shu et al., 2016
pronephros atp1a1a.5 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 5 with image from Shu et al., 2016
pronephric duct vH ionocyte ca2 expression decreased amount, abnormal prlihb183/ihb183 control Fig. 3 with image from Shu et al., 2016
OTHER TALEN1-prl TALEN PAGESNo links to external sites
CITATIONS (2)